Torimura, Takuji <br/><br/>
Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.  [electronic resource] 

 -  Neoplasia (New York, N.Y.)  07 2016 
 - 413-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5586 
<br/><br/><label>Standard No.: </label>10.1016/j.neo.2016.05.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Bone Marrow Cells--cytology<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Differentiation--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Disease Models, Animal<br/>Endothelial Progenitor Cells--cytology<br/>Human Umbilical Vein Endothelial Cells--cytology<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Mice, Nude<br/>Mice, Transgenic<br/>Neovascularization, Pathologic--drug therapy<br/>Receptors, Vascular Endothelial Growth Factor<br/>Recombinant Fusion Proteins--pharmacology<br/>Vascular Endothelial Growth Factor Receptor-1--metabolism<br/>Vascular Endothelial Growth Factor Receptor-2--metabolism